Once the funding begins, and with the successful recommendation by the KPMG report, the funding will be perpetual. Unlike RAP, PainChek just use results and they speaks for themselves. No coercion, incentive or force necessary.
PCK Price at posting:
7.7¢ Sentiment: Buy Disclosure: Held
